We are live on ! Find out more
Marshall Wace North America

Marshall Wace North America Portfolio holdings

AUM $23.5B Turnover 51.87%
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.6B
AUM Growth
+$1.47B
Cap. Flow
+$1.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
17.57%
Holding
1,695
New
602
Increased
310
Reduced
364
Closed
414
Avg Time Held
0.6 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.7 years

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$207M
2
PFE icon
Pfizer
PFE
+$171M
3
JNJ icon
Johnson & Johnson
JNJ
+$140M
4
SSNC icon
SS&C Technologies
SSNC
+$132M
5
MSFT icon
Microsoft
MSFT
+$131M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$158M
2
META icon
Meta Platforms (Facebook)
META
+$120M
3
BKNG icon
Booking.com
BKNG
+$106M
4
MRK icon
Merck
MRK
+$93.9M
5
IDXX icon
Idexx Laboratories
IDXX
+$92.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.74%
2 Technology 21.39%
3 Consumer Discretionary 13.38%
4 Industrials 12.54%
5 Financials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ZTS icon
1
Zoetis
ZTS
$32.8B
$431M 2.45%
3,459,641
+431,653
+14% +$52.1M
2013 Q2
25 quarters
BA icon
2
Boeing
BA
$150B
$408M 2.32%
1,073,165
+279,588
+35% +$99.9M
2017 Q1
10 quarters
MSFT icon
3
Microsoft
MSFT
$3.93T
$383M 2.18%
2,752,602
+955,739
+53% +$131M
2017 Q1
10 quarters
BSX icon
4
Boston Scientific
BSX
$64.3B
$352M 2%
8,653,688
+218,273
+3% +$9.25M
2017 Q1
10 quarters
AAPL icon
5
Apple
AAPL
$5.01T
$299M 1.7%
5,333,708
+3,962,200
+289% +$207M
2013 Q2
25 quarters
SEE icon
6
DELISTED
Sealed Air
SEE
$270M 1.54%
6,513,192
+132,204
+2% +$5.6M
2017 Q1
10 quarters
FIS icon
7
Fidelity National Information Services
FIS
$18.6B
$253M 1.44%
1,907,385
-608,222
-24% -$80.8M
2018 Q4
3 quarters
GILD icon
8
Gilead Sciences
GILD
$194B
$246M 1.4%
3,877,015
+458,819
+13% +$30M
2018 Q3
4 quarters
BABA icon
9
Alibaba
BABA
$271B
$224M 1.28%
1,342,020
+4,505
+0.3% +$774K
2017 Q2
9 quarters
HUM icon
10
Humana
HUM
$49.6B
$223M 1.27%
871,021
+334,746
+62% +$93.9M
2017 Q1
10 quarters
DGX icon
11
Quest Diagnostics
DGX
$25.9B
$220M 1.25%
2,056,112
+275,530
+15% +$28.3M
2017 Q1
10 quarters
USFD icon
12
US Foods
USFD
$22.1B
$219M 1.24%
5,316,935
-387,177
-7% -$14.9M
2017 Q4
7 quarters
TMO icon
13
Thermo Fisher Scientific
TMO
$255B
$211M 1.2%
725,548
+250,602
+53% +$71.8M
2018 Q4
3 quarters
DHR icon
14
Danaher
DHR
$161B
$211M 1.2%
1,649,531
-627,080
-28% -$78.5M
2013 Q4
23 quarters
ADBE icon
15
Adobe
ADBE
$95.4B
$208M 1.18%
751,633
-75,481
-9% -$22M
2013 Q3
24 quarters
PTC icon
16
PTC
PTC
$21B
$203M 1.15%
2,975,200
+979,611
+49% +$71.6M
2017 Q1
10 quarters
AMZN icon
17
Amazon
AMZN
$2.7T
$202M 1.15%
2,326,880
-833,800
-26% -$77.3M
2013 Q3
24 quarters
META icon
18
Meta Platforms (Facebook)
META
$1.81T
$185M 1.05%
1,038,041
-633,705
-38% -$120M
2013 Q3
24 quarters
TFX icon
19
Teleflex
TFX
$5.53B
$181M 1.03%
531,849
+51,915
+11% +$18.1M
2017 Q1
10 quarters
BERY icon
20
DELISTED
Berry Global Group, Inc.
BERY
$174M 0.99%
4,829,247
+144,397
+3% +$5.9M
2013 Q4
23 quarters
AVY icon
21
Avery Dennison
AVY
$13.3B
$171M 0.98%
1,510,042
+478,952
+46% +$54.6M
2018 Q3
4 quarters
FISV icon
22
Fiserv Inc
FISV
$25.3B
$167M 0.95%
1,613,987
+385,201
+31% +$39.3M
2017 Q4
7 quarters
PFE icon
23
Pfizer
PFE
$169B
$164M 0.93%
4,812,629
+4,692,850
+3,918% +$171M
2013 Q2
25 quarters
MRK icon
24
Merck
MRK
$360B
$160M 0.91%
1,991,860
-1,171,613
-37% -$93.9M
2017 Q1
10 quarters
SPGI icon
25
S&P Global
SPGI
$127B
$155M 0.88%
632,132
-144,451
-19% -$36.1M
2017 Q1
10 quarters
1
2 3 4 5

Similar funds

TPG Group Holdings (SBS) Advisors
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PFM Asset Management
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
Homrich & Berg
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
Marshall Wace Asia
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
36 South Capital Advisors
36 South Capital Advisors London, United Kingdom $3.76B AUM
H&F Corporate Investors VII
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
Deer VIII & Co
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace North America held 1,695 positions worth $17.6B, up 9.1% from $16.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $1.6B of net new capital in Q3 2019, opening 602 new positions and adding to 310 existing holdings. Its largest new stake was Johnson & Johnson: 1,065,531 shares worth $138M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $120M trimmed.

  • Marshall Wace North America's largest Q3 2019 buy was Johnson & Johnson: 1,065,531 shares worth $138M.
  • Marshall Wace North America added most to Apple in Q3 2019, an estimated $207M increase.
  • Marshall Wace North America's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $120M.
  • Marshall Wace North America fully exited Abbott in Q3 2019, selling an estimated $158M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $17.6B portfolio in Q3 2019.
  • Marshall Wace North America opened 602 new positions and closed 414 in Q3 2019.
  • Marshall Wace North America's portfolio value rose 9.1% quarter-over-quarter to $17.6B.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.